Skip to main content

Pfizer, Gilead Strike Multiyear Partnership To Manufacture COVID-19 Drug Remdesivir

Large-cap biopharma companies Pfizer Inc. and Gilead Sciences, Inc. announced a deal Friday for Gilead's remdesivir, which has been accorded emergency use authorization by the FDA for treating COVID-19.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.